Concepedia

Vibeke Hatorp

VH

Statistics

Publications

11

Citations

836

H-Index

11

Active since

1998

Affiliations

Novo Nordisk (Denmark)(Current)

Novo Nordisk (United States)

Vibeke Hatorp is an author at Novo Nordisk (Denmark) specializing in pharmacology, pharmacy, and pharmacokinetics.

Publications per year

1998–2003

11

Publications

11

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of a Single-Dose of NN2211, a Long-Acting Glucagon-Like Peptide 1 Derivative, in Healthy Male Subjects

B. Elbrønd, Grethe Jakobsen, Søren Erik Larsen et al. · Diabetes Care · 2002 · 282 citations · Full text

, , +13

Influence of Drugs Interacting with CYP3A4 on the Pharmacokinetics, Pharmacodynamics, and Safety of the Prandial Glucose Regulator Repaglinide

Vibeke Hatorp, Kristian T. Hansen, Mikael S. Thomsen · The Journal of Clinical Pharmacology · 2003 · 106 citations

, , +10

Single- and multiple-dose pharmacokinetics of repaglinide in patients with type 2 diabetes and renal impairment

Svenja Schumacher, I. Abbasi, Dale W. Weise et al. · European Journal of Clinical Pharmacology · 2001 · 95 citations

, , +16

Absorption, metabolism and excretion of a single oral dose of 14 C-repaglinide during repaglinide multiple dosing

P. N. M. van Heiningen, Vibeke Hatorp, Karin Kramer Nielsen et al. · European Journal of Clinical Pharmacology · 1999 · 82 citations

, , +5

Repaglinide pharmacokinetics in healthy young adult and elderly subjects

Vibeke Hatorp, W. C. Huang, Poul Strange · Clinical Therapeutics · 1999 · 67 citations

, , +14

1–5 of 11